{"id":"W2600462870","doi":"10.1200/jco.2012.30.15_suppl.531","title":"A randomized phase II study (VEG108838) of lapatanib plus pazopanib (L+P) versus lapatanib (L) in patients with ErbB2+ inflammatory breast cancer (IBC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Neutropenia; Clinical endpoint; Cohort; Placebo; Population; Randomized controlled trial; Pazopanib; Surgery; Cancer; Toxicity; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001681219,0.002115706,0.002422799,0.0004557731,0.0003789042,0.0009249948,0.001085686,0.001600692,0.006787508],"category_scores_gemma":[0.001502621,0.0008759951,0.001463382,0.0004304995,0.001254966,0.001125935,0.0005006362,0.00309525,0.001349102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001101843,"about_ca_system_score_gemma":0.001783598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00103356,"about_ca_topic_score_gemma":0.002894287,"domain_scores_codex":[0.9993283,0.0003842044,0.00002757893,0.0001123123,0.00004089369,0.0001067966],"domain_scores_gemma":[0.9990644,0.0001923531,0.0002456881,0.00007501422,0.00004013759,0.0003823761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.959623,0.01566387,0.0008498018,0.0003392849,0.0004851919,0.00005449879,0.00005154982,0.0004607127,0.005686651,0.00009618236,0.0009236047,0.01576573],"study_design_scores_gemma":[0.8917937,0.1057232,0.001128175,0.0000136551,0.0001730659,0.00003398529,0.00001276022,0.0002852648,0.0003272285,0.00008445281,0.0004152615,0.000009224968],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843553,0.00206431,0.0008474896,0.000935557,0.0004513306,0.007280885,0.001710005,0.0001539402,0.002201118],"genre_scores_gemma":[0.9799126,0.001804819,0.002020101,0.001477091,0.0004667539,0.009025539,0.001735655,0.00003641891,0.003520901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006787508,"threshold_uncertainty_score":0.02270645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1521543493657456,"score_gpt":0.5263324141883701,"score_spread":0.3741780648226245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}